Header Logo

Heather Gardner

Concepts (132)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Dog Diseases
14
2025
53
3.600
Why?
Osteosarcoma
7
2022
53
2.700
Why?
Bone Neoplasms
5
2022
115
2.280
Why?
Dogs
22
2025
316
1.440
Why?
Antineoplastic Agents
8
2019
628
1.250
Why?
Doxorubicin
3
2024
97
0.840
Why?
Lymphoma, Large B-Cell, Diffuse
4
2025
65
0.770
Why?
Pyrroles
3
2016
47
0.730
Why?
Indoles
3
2016
105
0.710
Why?
Histone-Lysine N-Methyltransferase
1
2019
31
0.640
Why?
Dystrophin
1
2019
31
0.630
Why?
Class I Phosphatidylinositol 3-Kinases
1
2018
10
0.600
Why?
Neoplasms
5
2023
1233
0.580
Why?
Lymphoma, Non-Hodgkin
1
2018
50
0.580
Why?
Mutation
3
2025
2458
0.510
Why?
Enzyme Inhibitors
1
2018
347
0.510
Why?
Splenic Neoplasms
1
2015
8
0.490
Why?
Hemangiosarcoma
1
2015
23
0.480
Why?
Animals
23
2025
19683
0.470
Why?
STAT3 Transcription Factor
3
2022
67
0.450
Why?
Proto-Oncogene Proteins c-kit
2
2018
31
0.280
Why?
Sulfonamides
2
2019
120
0.280
Why?
Carboplatin
2
2019
40
0.280
Why?
Antibodies, Monoclonal
2
2024
836
0.260
Why?
Genomics
3
2025
322
0.250
Why?
DNA Copy Number Variations
2
2025
65
0.250
Why?
Cell Line, Tumor
5
2022
1368
0.250
Why?
Whole Genome Sequencing
2
2025
63
0.210
Why?
Acrylamides
2
2023
15
0.210
Why?
Cell Proliferation
3
2022
942
0.200
Why?
Histones
1
2025
461
0.190
Why?
Gene Deletion
1
2022
293
0.180
Why?
Transcriptome
1
2023
343
0.170
Why?
Administration, Oral
2
2018
354
0.170
Why?
Dose-Response Relationship, Drug
2
2018
805
0.160
Why?
Apoptosis
2
2022
1033
0.160
Why?
Drug Discovery
1
2020
89
0.160
Why?
Leukemia, Mast-Cell
1
2018
1
0.150
Why?
Hydrazines
1
2018
10
0.150
Why?
Pyrimidines
1
2019
131
0.150
Why?
Disease Models, Animal
4
2023
2054
0.150
Why?
Male
11
2025
27796
0.150
Why?
Female
12
2025
30775
0.150
Why?
Cell Line
1
2022
1984
0.150
Why?
Lymphoma
1
2018
99
0.140
Why?
HSP90 Heat-Shock Proteins
1
2018
64
0.140
Why?
Sarcoma, Ewing
1
2017
11
0.140
Why?
Nanotubes
1
2017
23
0.140
Why?
Hyperthermia, Induced
1
2017
18
0.140
Why?
Rhabdomyosarcoma
1
2017
16
0.140
Why?
Phototherapy
1
2017
34
0.140
Why?
Aminopyridines
1
2017
31
0.140
Why?
Vinblastine
1
2016
18
0.140
Why?
Treatment Outcome
5
2018
5292
0.140
Why?
Drug Resistance, Neoplasm
1
2018
179
0.130
Why?
Pubic Bone
1
2016
1
0.130
Why?
Sarcoma, Experimental
1
2016
6
0.130
Why?
Spinal Neoplasms
1
2016
14
0.130
Why?
Carcinoma, Transitional Cell
1
2016
28
0.130
Why?
Sacrum
1
2016
24
0.130
Why?
Pyrazines
1
2016
33
0.130
Why?
Benzamides
1
2016
63
0.130
Why?
Urinary Bladder Neoplasms
1
2016
71
0.130
Why?
Protein-Tyrosine Kinases
1
2016
118
0.120
Why?
Carbazoles
1
2015
13
0.120
Why?
Tramadol
1
2015
16
0.120
Why?
Piroxicam
1
2015
3
0.120
Why?
Animals, Newborn
1
2015
230
0.120
Why?
Gold
1
2017
225
0.120
Why?
Protein Kinase Inhibitors
1
2016
170
0.120
Why?
Cyclophosphamide
1
2015
75
0.120
Why?
Tumor Suppressor Proteins
1
2016
194
0.120
Why?
Pain, Postoperative
1
2015
141
0.110
Why?
Lung Neoplasms
2
2017
584
0.110
Why?
Cells, Cultured
1
2018
2095
0.110
Why?
Skin Neoplasms
1
2015
398
0.090
Why?
Phosphorylation
3
2017
885
0.080
Why?
Transcription Factors
1
2016
1471
0.080
Why?
B-Lymphocytes
2
2024
550
0.070
Why?
Anorexia
2
2018
6
0.070
Why?
Xenograft Model Antitumor Assays
2
2018
178
0.070
Why?
Drug Therapy, Combination
2
2019
451
0.060
Why?
Disease-Free Survival
2
2016
228
0.060
Why?
Diarrhea
2
2016
75
0.060
Why?
Cell Survival
2
2017
559
0.060
Why?
Humans
7
2023
59473
0.060
Why?
Pilot Projects
2
2019
916
0.060
Why?
Antigens, CD20
1
2024
14
0.060
Why?
Medical Oncology
1
2023
57
0.050
Why?
Prospective Studies
2
2024
3071
0.050
Why?
Immunotherapy
1
2023
228
0.050
Why?
Mice
3
2018
10309
0.040
Why?
Triazoles
1
2018
51
0.040
Why?
Oncogenes
1
2018
66
0.040
Why?
Active Transport, Cell Nucleus
1
2018
108
0.040
Why?
Proteolysis
1
2018
136
0.030
Why?
Tumor Protein p73
1
2016
4
0.030
Why?
Lethargy
1
2016
3
0.030
Why?
Mast Cells
1
2016
41
0.030
Why?
Ureteral Obstruction
1
2016
14
0.030
Why?
Pelvic Floor
1
2016
10
0.030
Why?
Rectal Diseases
1
2016
27
0.030
Why?
Urologic Surgical Procedures, Male
1
2016
47
0.030
Why?
Interleukin-8
1
2016
87
0.030
Why?
Proto-Oncogene Proteins c-bcl-2
1
2016
99
0.030
Why?
Drug Evaluation, Preclinical
1
2016
89
0.030
Why?
Protein Isoforms
1
2016
192
0.030
Why?
Drug Administration Schedule
1
2016
284
0.030
Why?
Gene Knockdown Techniques
1
2016
194
0.030
Why?
Neoplasm Invasiveness
1
2016
248
0.030
Why?
Neovascularization, Pathologic
1
2016
137
0.030
Why?
Administration, Metronomic
1
2015
2
0.030
Why?
Vomiting
1
2016
133
0.030
Why?
Osteoblasts
1
2016
195
0.030
Why?
Mice, SCID
1
2016
513
0.030
Why?
Neutropenia
1
2015
62
0.030
Why?
Vascular Endothelial Growth Factor A
1
2016
197
0.030
Why?
Ultrasonography
1
2016
458
0.030
Why?
Tumor Suppressor Protein p53
1
2016
289
0.030
Why?
Regression Analysis
1
2015
487
0.030
Why?
Kaplan-Meier Estimate
1
2015
396
0.030
Why?
Pain Measurement
1
2015
327
0.030
Why?
Weight Loss
1
2016
263
0.030
Why?
Gene Expression Regulation, Neoplastic
1
2016
474
0.030
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2015
202
0.030
Why?
Cytokines
1
2017
912
0.030
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2016
402
0.030
Why?
RNA Interference
1
2016
590
0.030
Why?
Reproducibility of Results
1
2016
1561
0.020
Why?
RNA, Small Interfering
1
2016
858
0.020
Why?
Analgesics, Opioid
1
2015
488
0.020
Why?
Tomography, X-Ray Computed
1
2016
1515
0.020
Why?
Gardner's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (132)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_